Nuformix plc (LON:NFX) targets unmet needs in fibrosis and oncology via drug repurposing, focusing on partnering its NXP002 lead program for IPF and PPF...
hVIVO expands its clinical footprint by acquiring CRS, a German CRO, adding Phase I & II trial capabilities in Europe, enhancing strategic growth for 2025-2026...
Explore the JPMorgan European Discovery Trust's latest performance review, highlighting key sectors and stocks influencing returns as it targets 2025 goals...
Pets at Home Group Plc (LON:PETS) reports Q3 FY25 financials, showing a 2.3% consumer revenue rise to £468.0m, driven by strong Vet Group performance...
Bluefield Solar Income Fund declares a 2.20 pence interim dividend per share for FY ending June 2025, reaffirming its dividend guidance of 8.90 pence...
Molten Ventures plc appoints Andrew Zimmermann as Director and CFO, effective January 2025, marking a pivotal step in the company's financial leadership...
GSK's depemokimab, an ultra-long-acting biologic, is up for regulatory review in China and Japan for asthma and CRSwNP, based on positive trial results...
Aptamer Group plc reports progress on key projects in its H1 2025 trading update, highlighting partnerships with Unilever and Alzheimer's biomarker validation...
WH Smith explores strategic options, including a possible sale, for its profitable High Street business as it focuses on its global Travel retail division...
Schroder AsiaPacific Fund plc appoints Nicky Richards as an independent non-executive Director, enhancing its board with her vast investment expertise...
Diversified Energy acquires Maverick Natural Resources for $1.275 billion, boosting production scale, free cash flow, and sustainable long-term growth...
Nuformix plc (LON:NFX) targets unmet needs in fibrosis and oncology via drug repurposing, focusing on partnering its NXP002 lead program for IPF and PPF...
hVIVO expands its clinical footprint by acquiring CRS, a German CRO, adding Phase I & II trial capabilities in Europe, enhancing strategic growth for 2025-2026...
Explore the JPMorgan European Discovery Trust's latest performance review, highlighting key sectors and stocks influencing returns as it targets 2025 goals...
Pets at Home Group Plc (LON:PETS) reports Q3 FY25 financials, showing a 2.3% consumer revenue rise to £468.0m, driven by strong Vet Group performance...
Bluefield Solar Income Fund declares a 2.20 pence interim dividend per share for FY ending June 2025, reaffirming its dividend guidance of 8.90 pence...
Molten Ventures plc appoints Andrew Zimmermann as Director and CFO, effective January 2025, marking a pivotal step in the company's financial leadership...
GSK's depemokimab, an ultra-long-acting biologic, is up for regulatory review in China and Japan for asthma and CRSwNP, based on positive trial results...
Aptamer Group plc reports progress on key projects in its H1 2025 trading update, highlighting partnerships with Unilever and Alzheimer's biomarker validation...
WH Smith explores strategic options, including a possible sale, for its profitable High Street business as it focuses on its global Travel retail division...
Schroder AsiaPacific Fund plc appoints Nicky Richards as an independent non-executive Director, enhancing its board with her vast investment expertise...
Diversified Energy acquires Maverick Natural Resources for $1.275 billion, boosting production scale, free cash flow, and sustainable long-term growth...
